[{"Assets_0_FY_USD":251377000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":34783000.0,"NetIncomeLoss_1_FY_USD":5434000.0,"NetIncomeLoss_4_FY_USD":23849000.0,"PaymentsOfDividendsCommonStock_4_FY_USD":21170000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":42754000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":42325000.0,"StockholdersEquity_0_FY_USD":175418000.0,"EarningsPerShareBasic_1_FY_USD":0.13,"EarningsPerShareBasic_4_FY_USD":0.56,"EarningsPerShareDiluted_1_FY_USD":0.13,"EarningsPerShareDiluted_4_FY_USD":0.56,"Ticker":"VIVO","CIK":"794172","name":"MERIDIAN BIOSCIENCE INC","OfficialName":"Meridian Bioscience Inc. Common Stock","form":"10-K","period":"20180930","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1192599275.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20181129"}]